{"id":"W4391558646","doi":"10.2337/db23-0377","title":"Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in China","year":2024,"lang":"en","type":"article","venue":"Diabetes","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Peripheral neuropathy; Internal medicine; Diabetes mellitus; Clinical endpoint; Randomized controlled trial; Adverse effect; Diabetic neuropathy; Clinical trial; Incidence (geometry); Gastroenterology; Surgery; Anesthesia; Endocrinology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001699966,0.001387445,0.00298664,0.0005400499,0.0004716258,0.0006729962,0.0006930461,0.001355972,0.002602558],"category_scores_gemma":[0.000859898,0.00045968,0.002346895,0.0005721508,0.0009273139,0.0005594328,0.0003705259,0.001340317,0.0002749337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007913611,"about_ca_system_score_gemma":0.00235927,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002542176,"about_ca_topic_score_gemma":0.005579534,"domain_scores_codex":[0.9995364,0.0002230015,0.00003225421,0.00007714615,0.00004339339,0.00008777918],"domain_scores_gemma":[0.9996282,0.00004812872,0.0000876147,0.00002992162,0.00004680312,0.0001593269],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9183134,0.01468826,0.002045657,0.002391831,0.002544324,0.0001768905,0.0001186983,0.0009226801,0.009232474,0.0002352099,0.001683327,0.04764718],"study_design_scores_gemma":[0.9470438,0.04782316,0.002855613,0.00004379108,0.0006085515,0.00003323846,0.00001872463,0.000599771,0.0004260418,0.00009982304,0.0004301249,0.00001737414],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861122,0.007239596,0.0007538259,0.0007062018,0.0002717767,0.003269842,0.0005013667,0.0001112887,0.001033927],"genre_scores_gemma":[0.9825097,0.005331138,0.00212923,0.001897675,0.0002518145,0.005027377,0.0009471839,0.00002091469,0.001885046],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00298664,"threshold_uncertainty_score":0.008990407,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03442803547815516,"score_gpt":0.3631988888331649,"score_spread":0.3287708533550098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}